In phase

I

testing of a new drug designed to increase the red blood cell count, a researcher obtains envelopes with the names and addresses of all treated subjects. She wants to increase the dosage in a sub-sample of

32

subjects, so she thoroughly mixes all of the envelopes in a bin, then pulls

32

of those envelopes to identify the subjects to be given the increased dosage